biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > 18 & 4

<< Previous

Bullboard Posts

Next >>

Comment by chrispion May 10, 2021 4:56pm

162 Views

Post# 33170061

RE:18 & 4

Any guesses on what the SP will be by Friday? 18 pennies in 4 days looks like a real possibility!!

I'll gladly be buying any shares from people not thinking 3-6 months out from here when any COVID delays that have occurred will be a distant memory.

I could definately use another G63 in my garage for Christmas this year!

Don't trade your gold bar for some copper coins (25 pennies to be exact).

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages